Renal Failure, Drug Pharmacokinetics and Drug Action
- 1 May 1976
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 1 (2) , 99-120
- https://doi.org/10.2165/00003088-197601020-00002
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Drug Protein Binding and the Nephrotic SyndromeClinical Pharmacokinetics, 1976
- Kinetics of diphenylhydantoin in uraemic patients: Consequences of decreased plasma protein bindingEuropean Journal of Clinical Pharmacology, 1974
- CLOFIBRATE, NEPHROTIC SYNDROME, AND HISTOLOGICAL CHANGES IN MUSCLEThe Lancet, 1973
- The subcellular basis for the mechanism of inotropic action of cardiac glycosides.1971
- Protein Binding of Diphenylhydantoin and Desmethylimipramine in Plasma from Patients with Poor Renal FunctionNew England Journal of Medicine, 1971
- Permeability changes in experimental uremic encephalopathy.1970
- ABNORMAL PHARMACOKINETICS OF PHENYTOIN IN A PATIENT WITH URÆMIAThe Lancet, 1970
- CARBOHYDRATE METABOLISM IN UREMIA: BLOOD GLUCOSE RESPONSE TO SULFONYLUREAThe Lancet Healthy Longevity, 1967
- The Blood-cerebrospinal Fluid Barrier in UremiaAnnals of Internal Medicine, 1962
- [Synthetic curare-like substances in man].1951